Maverick Capital Ltd
Source: SEC Form 13F · as of Mar 2026Maverick Capital Ltd holds 26 biotech & pharma companies tracked by BioSniper, totaling $1.36B in value as of Mar 2026 (SEC Form 13F).
Companies held
26
Total value held
$1.36B
| Company | Shares | Value |
|---|---|---|
| TECHBIO-TECHNE Corp | 4,739,721 | $247.7M |
| ABTABBOTT LABORATORIES | 1,758,160 | $180.5M |
| RGENREPLIGEN CORP | 1,518,805 | $178.9M |
| PMPhilip Morris International Inc | 567,250 | $93.8M |
| MOHMolina Healthcare Inc | 645,768 | $86.1M |
| WVEWave Life Sciences Ltd. | 11,317,399 | $82.1M |
| PCVXVaxcyte, Inc. | 1,377,738 | $80.1M |
| NVONovo Nordisk A/S | 2,080,121 | $76.4M |
| CNTACentessa Pharmaceuticals plc | 1,854,488 | $73.7M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 2,186,402 | $70.0M |
| MMSIMerit Medical Systems Inc. | 714,081 | $49.2M |
| ROIVRoivant Sciences Ltd. | 1,626,940 | $45.1M |
| ACHCAcadia Healthcare Company Inc. | 1,314,116 | $30.7M |
| IVVDInvivyd, Inc. | 18,970,913 | $24.7M |
| RCKTRocket Pharmaceuticals Inc. | 3,567,372 | $12.8M |
| QUREuniQure N.V. | 697,640 | $11.4M |
| ELANElanco Animal Health Inc | 144,457 | $3.5M |
| NVSNovartis AG | 15,247 | $2.3M |
| GUTSFractyl Health Inc. | 3,974,806 | $1.8M |
| ICLRICON plc | 13,887 | $1.5M |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 8,178 | $1.4M |
| GMEDGlobus Medical Inc. | 15,660 | $1.3M |
| CRBUCaribou Biosciences, Inc. | 652,542 | $1.2M |
| SNYSanofi | 24,581 | $1.2M |
| DGXQuest Diagnostics Incorporated | 2,756 | $540K |
| CRISCURIS INC | 49,554 | $6K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.